In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the ...

Recent research found a correlation between the upfront time to build and release a clinical database and its impact on downstream data management processes in conducting and completing trials.

[2] This is rather ironic, given that well-designed clinical trials should be amenable to very simple data handling and analysis. [3] Indeed the flowchart established by the CONSORT (Consolidated ...